chr2-189451887-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_032168.3(WDR75):āc.365A>Gā(p.Glu122Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000206 in 1,459,674 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032168.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
WDR75 | NM_032168.3 | c.365A>G | p.Glu122Gly | missense_variant | 4/21 | ENST00000314761.9 | NP_115544.1 | |
WDR75 | NM_001303096.2 | c.173A>G | p.Glu58Gly | missense_variant | 5/22 | NP_001290025.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
WDR75 | ENST00000314761.9 | c.365A>G | p.Glu122Gly | missense_variant | 4/21 | 1 | NM_032168.3 | ENSP00000314193 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000797 AC: 2AN: 250836Hom.: 0 AF XY: 0.00000738 AC XY: 1AN XY: 135592
GnomAD4 exome AF: 0.00000206 AC: 3AN: 1459674Hom.: 0 Cov.: 29 AF XY: 0.00000275 AC XY: 2AN XY: 726254
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.365A>G (p.E122G) alteration is located in exon 4 (coding exon 4) of the WDR75 gene. This alteration results from a A to G substitution at nucleotide position 365, causing the glutamic acid (E) at amino acid position 122 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at